Among the various ferroptosis-associated factors, serum levels of sTfR1 and GPX4 as well as sTfR1/GPX4 revealed a strong prognostic value and may serve as future risk-associated biomarkers for patients diagnosed with COPD. This evidence concerns the gene GPX4 and chronic obstructive pulmonary disease.